Latest Insider Transactions at Hcw Biologics Inc. (HCWB)
This section provides a real-time view of insider transactions for Hcw Biologics Inc. (HCWB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCW Biologics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCW Biologics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Hing C Wong Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
739,288
+4.4%
|
$739,288
$1.4 P/Share
|
|
Feb 20
2024
|
Rebecca Byam Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
760,714
+35.5%
|
$760,714
$1.4 P/Share
|
|
Feb 20
2024
|
Lee Flowers SVP of Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
71,429
+27.3%
|
$71,429
$1.4 P/Share
|
|
Feb 20
2024
|
Scott T Garrett |
BUY
Grant, award, or other acquisition
|
Indirect |
142,858
+34.78%
|
$142,858
$1.4 P/Share
|
|
Feb 20
2024
|
Lisa M. Giles |
BUY
Grant, award, or other acquisition
|
Direct |
35,715
+49.93%
|
$35,715
$1.4 P/Share
|
|
Feb 20
2024
|
Rick S. Greene |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+44.73%
|
$35,714
$1.4 P/Share
|
|
Dec 11
2023
|
Peter Rhode Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+15.3%
|
$0
$0.14 P/Share
|
|
Dec 08
2023
|
Lee Flowers SVP of Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
7,501
+5.94%
|
$0
$0.14 P/Share
|
|
Nov 17
2023
|
Peter Rhode Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.11%
|
$0
$0.14 P/Share
|
|
Oct 19
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,249
+7.07%
|
$0
$0.14 P/Share
|
|
Sep 14
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+0.01%
|
$3,600
$2.08 P/Share
|
|
Sep 14
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,041
+2.96%
|
$2,082
$2.07 P/Share
|
|
Sep 13
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.86%
|
$10,000
$2.1 P/Share
|
|
Sep 13
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
546
+1.67%
|
$1,092
$2.03 P/Share
|
|
Sep 12
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.87%
|
$10,000
$2.09 P/Share
|
|
Sep 12
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
500
+3.14%
|
$1,000
$2.05 P/Share
|
|
Sep 11
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.88%
|
$10,000
$2.05 P/Share
|
|
Sep 11
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
99
+0.66%
|
$198
$2.05 P/Share
|
|
Sep 08
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1
+0.01%
|
$1
$1.9 P/Share
|
|
Sep 08
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.89%
|
$10,000
$2.02 P/Share
|
|
Sep 07
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.89%
|
$5,000
$1.95 P/Share
|
|
Sep 07
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
63
+0.42%
|
$63
$1.95 P/Share
|
|
Sep 06
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.9%
|
$5,000
$1.95 P/Share
|
|
Sep 05
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
400
+2.64%
|
$400
$1.75 P/Share
|
|
Jun 09
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.55%
|
$40,000
$2.06 P/Share
|
|
Jun 08
2023
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
10,000
+8.24%
|
$20,000
$2.16 P/Share
|
|
Jun 08
2023
|
Lee Flowers SVP of Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,356
+5.02%
|
$0
$0.14 P/Share
|
|
Jun 08
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,696
+0.89%
|
$9,392
$2.21 P/Share
|
|
Jun 07
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.71%
|
$40,000
$2.03 P/Share
|
|
Jun 06
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
19,062
+3.68%
|
$19,062
$1.82 P/Share
|
|
Jun 05
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.0%
|
$20,000
$1.67 P/Share
|
|
Jun 02
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.01%
|
$800
$1.54 P/Share
|
|
Jun 01
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.01%
|
$800
$1.62 P/Share
|
|
May 31
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.01%
|
$2,000
$1.55 P/Share
|
|
May 31
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
500
+3.37%
|
$500
$1.5 P/Share
|
|
May 30
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.02%
|
$3,000
$1.55 P/Share
|
|
May 30
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
850
+5.78%
|
$850
$1.52 P/Share
|
|
May 26
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.17%
|
$20,000
$1.66 P/Share
|
|
May 25
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.35%
|
$20,000
$1.62 P/Share
|
|
May 24
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.54%
|
$20,000
$1.61 P/Share
|
|
May 23
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,036
+1.24%
|
$5,036
$1.57 P/Share
|
|
May 22
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,450
+7.8%
|
$33,450
$1.53 P/Share
|
|
Nov 02
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+8.53%
|
$0
$0.14 P/Share
|
|
Sep 14
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.37%
|
$30,000
$2.58 P/Share
|
|
Sep 13
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.57%
|
$30,000
$2.58 P/Share
|
|
Sep 12
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+4.79%
|
$30,000
$2.65 P/Share
|
|
Sep 09
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$12,000
$2.7 P/Share
|
|
Sep 08
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.03%
|
$8,000
$2.67 P/Share
|
|
Sep 07
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$12,000
$2.58 P/Share
|
|
Sep 02
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.03%
|
$8,000
$2.55 P/Share
|